Randomized controlled trial comparing the therapeutic effects and safety of alogliptin and linagliptin in type 2 diabetic patients associated with diabetic nephropathy
Latest Information Update: 14 Feb 2017
At a glance
- Drugs Alogliptin (Primary) ; Linagliptin
- Indications Diabetic neuropathies; Type 1 diabetes mellitus
- Focus Therapeutic Use
- 13 Feb 2017 Status changed to discontinued.
- 03 Dec 2014 New trial record